Jeffrey M. Leiden - 24 Feb 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
24 Feb 2026
Net transactions value
-$1,720,685
Form type
4
Filing time
26 Feb 2026, 18:11:08 UTC
Previous filing
19 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LEIDEN JEFFREY M Executive Chairman, Director C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 26 Feb 2026 0001242825

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,720,685 -3,547 -9.3% $485.11 34,797 24 Feb 2026 Direct
holding VRTX Common Stock 440 24 Feb 2026 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.